Investigation using data of a large number of cases made available by others [40] revealed that AML1 transcript levels were higher in CML-BC than CML-CP patients and the difference was statistically significant (p<0.001) (Figure S1). The gene discussed is RUNX1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.